Development of a nanoscale screening assay for the rapid optimisation of biopharmaceuticals
Biopharmaceutical development is often delayed in part by the extensive stability analysis and formulation refinement entailed in the early stages. Determination of a suitable therapeutic protein or peptide and the ideal formulation requires consideration of t he delivery route, dose and the stabili...
Main Author: | Croad, Oliver William |
---|---|
Published: |
University of Nottingham
2014
|
Subjects: | |
Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.755823 |
Similar Items
-
Development and characterisation of polymeric nano-carriers for oral delivery of biopharmaceuticals
by: Li, Ruiying
Published: (2017) -
Application of multivariate data analysis in biopharmaceutical production
by: Ritchie, Elspeth Kathryn
Published: (2016) -
Development and validation of assays used to evaluate STAT3 inhibitors
by: Chamberlain, Christopher Daniel
Published: (2017) -
Development of ICP-MS assays for the study and prediction of the efficacy and side effects of Pt-based drugs in cancer chemotherapy
by: Zayed, Aref
Published: (2012) -
Combating antibiotic resistance in clinical practice : optimising antibiotic and infection control practices
by: Alnajjar, Munther Saleh Numan A.
Published: (2016)